%0 Journal Article
%T Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson¡¯s disease without cognitive impairment
%A Andrew R. Mayes
%A Julius Sim
%A Keira Watts
%A Laura Longshaw
%A Michael Murray
%A Nicola M. J. Edelstyn
%A Simon J. Ellis
%A Thomas A. Shepherd
%J Archive of "Pilot and Feasibility Studies".
%D 2018
%R 10.1186/s40814-017-0154-7
%X CONSORT diagram showing key stages of study desig
%K Feasibility study
%K Crossover
%K Medication withdrawal
%K Pramipexole PR
%K Ropinirole MR
%K Idiopathic Parkinson¡¯s disease
%K Cued recall
%K Safety processes
%K Acceptability
%K Barriers to participation
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501424/